Abstract:Background. The tumor microenvironment (TME) plays a crucial role in the initiation and progression of cancer. Bladder cancer (BLCA) is a malignant tumor of the genitourinary system. Its heterogeneity results in significant differences in the prognosis of patients. To date, this is still a huge challenge for clinical treatment. In recent years, more and more evidence showed that dysregulation of transcription factors (TFs) plays an important role in tumor progression, invasion, and metastasis. Unfortunately, the role of TFs on the tumor microenvironment in bladder cancer is unclear. Methods. The original data of BLCA and corresponding adjacent tissues were obtained from The Cancer Genome Atlas (TCGA) database. TFs were downloaded from the Animal Transcription Factor DataBase (Animal TFDB). Intersection analysis was used to obtain TFs that were differentially expressed between tumor and adjacent tissues. Gene Set Cancer Analysis (GSCALite) and CIBERSORT software were used to reveal the key differentially expressed TFs (DE-TFs). Subsequently, UALCAN and Human Protein Atlas (HPA) databases were used to disclose the expression of key DE-TFs in BLCA. The K-M curve divulged the relationship between the key DE-TFs and the patient's overall survival (OS), and the univariate and multivariate Cox regression analyses were conducted to explore independent prognostic factors. The cluster profiler package and Gene Set Enrichment Analysis (GSEA) were used for functional enrichment of genes related to the key DE-TFs. Finally, CIBERSORT software analyzed the immune landscape of BLCA. Results. We obtained a total of 117 BLCA-related DE-TFs. Among them, ETV7 was identified as the key DE-TFs due to its association with the autophagy activation pathway and various immune cells in cancer. Online databases of UALCAN and HPA indicated that ETV7 was overexpressed in tumors and negatively correlated with tumor severity. The K-M curve showed that the OS of patients with high expression of ETV7 was poor, which indicated that it was an independent prognostic factor. Functional enrichment of 87 DEGs between ETV7-high and -low expression groups indicated that it was closely related to the immune response and the functions of a variety of immune cells. Finally, CIBERSORT results proved that the high and low expression of ETV7 also caused significant differences in the tumor immune microenvironment of patients. Conclusion. Overall, we proved that the transcription factor ETV7 was a novel prognostic factor, which may improve the individualized outcome prediction in BLCA by regulating the tumor immune microenvironment.

Identification of ETV5 as a prognostic marker related to epigenetic modification in pan-cancer and facilitates tumor progression in hepatocellular carcinoma

ETV4 is a Theranostic Target in Clear Cell Renal Cell Carcinoma That Promotes Metastasis by Activating the Pro-Metastatic Gene FOSL1 in a PI3K-AKT Dependent Manner.

Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma

Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysis

Ets Variant 5 Promotes Colorectal Cancer Angiogenesis By Targeting Platelet-Derived Growth Factor Bb

ETV5 Overexpression Promotes Progression of Esophageal Squamous Cell Carcinoma by Upregulating SKA1 and TRPV2

The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression

ETV5 Transcriptionally Activates TGFβ1 and Promotes Cancer Cell Invasion and Migration of NSCLC.

Altered Expression of ETV1 and Its Contribution to Tumorigenic Phenotypes in Gastrointestinal Stromal Tumors.

Biological and Prognostic Value of ETV5 in High-Grade Serous Ovarian Cancer

ETV5-mediated Upregulation of Lncrna CTBP1-DT As a Cerna Facilitates HGSOC Progression by Regulating Mir-188-5p/map3k3 Axis.

Eg5 As a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

Identification of Prognostic miRNAs Targeting EZH2 in Hepatocellular Carcinoma Using The Cancer Genome Atlas Database

Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment

ETV1 Positively Correlated with Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer.

Identification of CERS5 as a novel biomarker for prognosis and immunity in hepatocellular carcinoma: a bioinformatics analysis and functional validation study

ETV5 expression positively correlates with promoter methylation and predicts response for 5-FU-based adjuvant therapy response in proximal colon cancer

Comprehensive Analysis Identified ETV7 As a Potential Prognostic Biomarker in Bladder Cancer

High EIF2B5 Mrna Expression and Its Prognostic Significance in Liver Cancer: a Study Based on the TCGA and GEO Database

HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET